Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort pMDI in Children with Asthma
NCT02091986Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of budesonide + formoterol in asthma, sponsored by AstraZeneca. Started Apr 2014; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02091986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02091986.